Pharmaceutical Regulatory Affairs Coference, Pharma, Pharmacy Exhibition 2012
2nd International Conference and Exhibition on
Pharmaceutical Regulatory Affairs
November 23-24, 2012 Hyderabad International Convention Centre, India
Pharma-2012

    Previous Events
     
     
    Participants List in Academia
    Untitled Document
    University of Texas at Arlington, USA

    Stanford University School of Medicine, USA

    Mahidol University, Thailand

    Amirkabir University of Technology, Iran

    Hamdard University, India

    Yeshiva University, USA

    University of Macau, China

    Monash University, Australia

    University of Michigan, Ann Arbor

    Universidade Federal do Rio de Janeiro, Brazil

    University of Denver, Colorado

    University of Toronto, Canada

    Zagazig University, Egypt

    Banaras Hindu University, India

    Taipei Medical University, Taiwan

    University di Messina CNISM, Italy

    University of Tasmania, Australia

    Huazhong University of Science and Technology, China

    Sogang University, Korea

    University of Edinburgh, UK

    Martin-Luther-University Halle-Wittenberg, USA

    Universidade de Sao Paulo, Brazil

    Eve University, Turkey

    University of Delhi, India

    Isfahan University of Technology(IUT), Iran

    Taif University, Saudi Arabia

    University Medical Center, Netherlands

    University of Copenhagen, Denmark

    University Paris 13, France

     
    Participants List From Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Women's Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddy's labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria


     
    Upcoming Conferences
    Day 1
    Scientific Program
      Day 2
    Scientific Program
    2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs, Pharma-2012, will be organized around the theme "Concepts, Challenges and Opportunities in Regulatory Strategy."

    Pharma-2012 is comprised of 11 tracks and 48 sessions designed to offer comprehensive sessions that address current issues in pharmaceutical Regulatory Affairs.

    Submit your abstract to any of the following tracks.

    Register now for the conference by choosing an appropriate package suitable to you.
    Abstract Submission   Register
    Renowned Speakers
    speaker Pradeep K. Karla
    Howard University, USA

    speaker Deepa Arora
    Lupin Limited, India

    speaker Sunita Sharma
    Ocimum Bio Solutions, USA

    speaker Laerte Dall’Agnol
    DALL Solucoes Analíticas e Empresariais, Brazil

    speaker S. V. Eswaran
    University of Delhi, India

    speaker Naser L. Rezk
    King Saud bin Abdul-Aziz University for Health Sciences, Saudi Arabia

    speaker Bahrudin Ibrahim
    Universiti Sains Malaysia, Malaysia

    speaker Bobby George
    Reliance Life Sciences, India

    speaker N. Rajasekar
    SiliCycle Inc., Canada

    speaker Mallika Rajasekaran
    Aris Global Software Private Limited, India

    speaker Andrea Laslop
    Austrian Agency for Health and Food Safety, Austria

    speaker S V Krishna prasad
    Cito Healthcare Pvt. Ltd, India

    speaker Maryse Picher
    Zintro Inc and CFRx Raleigh-Durham, USA

    speaker Sudhakar Akul Yakkanti
    Boys Town National Research Hospital, USA

    speaker Shivanand Puthli
    Panacea Biotec Ltd., India

    speaker Lise Aagaard
    University of Southern Denmark, Denmark

    speaker Patrick L. Leoni
    Euromed Management, France

    speaker Silvia Lima Costa
    Universiade Federal da Bahia, Brazil

    Track 1: Regulatory Affairs for Healthcare Products  
    Track 1-1 Pharmaceuticals
    Track 1-2 Medical devices
    Track 1-3 Biologics and biotechnology products
    Track 1-4 Cosmetics
    Track 1-5 Veterinary products
    Track 2: Biologics and Medical Devices
    Track 2-1 Clinical trial design for medical devices
    Track 2-2 Biologics and design control
    Track 2-3 Process validation for drugs and biologics
    Track 2-4 Bioengineered pharmaceutical products
    Track 3: Drug Development and NDDS
    Track 3-1 New strategies for drug development
    Track 3-2 Drug delivery systems by nano technology
    Track 3-3 Transmucosal and topical drug delivery systems
    Track 3-4 Novel therapeutic approaches and future trends
    Track 4: Drug Interactions and Toxicity
    Track 4-1 Epidemiology of drug interactions
    Track 4-2 Food/alcohol drug interactions
    Track 4-3 Drug toxicity and adverse drug reactions
    Track 4-4 Pharmacokinetics and pharmacodynamics
    Track 5: Biologics, Novel Therapies and other Special Categories
    Track 5-1 Biological products
    Track 5-2 Blood and blood products
    Track 5-3 Cells, tissues, organs, gene therapy, cloning
    Track 5-4 Radiopharmaceuticals
    Track 6: OTC Drug Products, Herbal Medicines, and Homeopathic Medicines
    Track 6-1 Homeopathic medicines
    Track 6-2 Herbal and ayurvedic products
    Track 6-3 Vaccines
    Track 6-4 Narcotics/controlled drugs
    Track 7: Safety and Quality Regulation
    Track 7-1 New drug development
    Track 7-2 Medical device development
    Track 7-3 Biologics development
    Track 7-4 Prescription drugs
    Track 7-5 Drug dosage and labelling
    Track 8: Business and Law Enforcement and Education
    Track 8-1 The business of pharmacy, medicine and biotechnology
    Track 8-2 Understanding the health care landscape
    Track 8-3 Regulatory culture in food and drug administration
    Track 8-4 Biomedical product development: From boardroom to market
    Track 8-5 Importance of personnel training and education in regulatory affairs
    Track 9: Biomedical Intellectual Property Management
    Track 9-1 Global biotechnology product registration: E.U., U.S. product regulation
    Track 9-2 Quality (chemistry/manufacturing Controls), safety and efficacy issues
    Track 9-3 Intellectual property law for generics and innovator rights
    Track 9-4 Patents in the pharmaceutical industry: Legal & ethical Issues
    Track 10: Regulatory Compliances in Health Care
    Track 10-1 FDA and EU regulatory policies
    Track 10-2 Regulatory aspects of NDA and ANDA: Regulatory filing and submissions
    Track 10-3 Compliance programs and policy guides
    Track 10-4 GMP, GCP, GLP and GRPs
    Track 11: Novel Strategies for Growth in the Pharma and Regulatory Environment
    Track 11-1 Regulatory issues, quality control, and business development
    Track 11-2 Clinical trials in emerging markets
    Track 11-3 Benefit/risk assessment during drug development
    Track 11-4 Strategic development towards FDA approval
    Track 11-5 Regulatory challenges in nano and biotech therapeutics
     
    follow
    Conference Secretariat: Pharma-2012, OMICS Group Conference
    5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Phone: +1- 650-268-9744 l Fax: +1-650-618-1414
    Toll free: 1-800-216-6499(USA & Canada) l 1-800-651-097(Australia)
    E-mail: pharma2012@omicsonline.us | pharma2012@omicsgroup.co
    Operated by: Editors - Journal of Bioanalysis & Biomedicine, Pharmaceutical Regulatory Affairs: Open Access and Journal of Pharmaceutics & Drug Delivery Research
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version